EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Efficacy of Local Application of a Combined Metronidazole and Minocycline Ointment in the Non‐Surgical Treatment of Peri‐Implantitis: A Preclinical In Vivo Study

Jin‐Young Park, Seung‐Hyun Park, Chang‐Sung Kim

Journal of Clinical Periodontology · 2026-12 · 53 (12) · 1762-1772

DOI: 10.1111/jcpe.70203 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Aim To evaluate the adjunctive effect of locally delivered metronidazole–minocycline (Met/Mc) versus minocycline (Mc) ointment and mechanical debridement alone in non‐surgical treatment of peri‐implantitis. Materials and Methods Peri‐implantitis was induced through ligature in a canine model. Implants were allocated to mechanical debridement (control), Mc or Met/Mc. Probing depth (PD), bleeding on probing (BOP), marginal bone levels (MBLs) and immunohistochemical parameters (CD3, CD20, IgG) were assessed over 12 weeks. Results Both Met/Mc and Mc showed significantly greater PD reductions than control (Δ −5.33 ± 1.35 mm and −3.67 ± 1.89 mm vs. −0.04 ± 1.80 mm; p < 0.0001 and p = 0.0004). BOP and MBL reductions were significantly greater in Met/Mc than Mc and control (BOP: Δ −5.67 ± 0.71 vs. −3.22 ± 2.54 vs. −0.78 ± 1.99, p = 0.020; MBL: Δ −2.41 ± 1.21 vs. −0.80 ± 0.21 vs. +0.64 ± 0.93 mm, p = 0.0035). Met/Mc showed significantly lower CD3, CD20 and IgG than the control and lower CD20 and IgG than Mc (all p < 0.05). Conclusion In this preclinical model, adjunctive Met/Mc ointment yielded greater clinical and radiographic improvements than both comparators, accompanied by reduced B‐cell and plasma‐cell infiltration. These findings provide preclinical proof of concept, however, warranting clinical confirmation.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →